All In Biotech

Drug Trial Radar · NCT00410631

Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma

NB2004 Trial Protocol for Risk Adapted Treatment of Children With Neuroblastoma

Last checked: Nov 20, 2026Latest source record: Aug 7, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 642 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

642

Planned (sponsor's estimate)

Start

Oct 2004

Primary completion

Dec 2010

Sponsor

Sponsor type
Academic, hospital or other
First posted
Dec 13, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Masking
None
Primary purpose
Treatment
Who can join
All sexes, up to 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving combination chemotherapy may kill more tumor cells. Radiation therapy uses high-energy x-rays to kill tumor cells. An autologous stem cell transplant may be able to replace blood-forming cells that were destroyed by chemotherapy and radiation therapy. This may allow more chemotherapy to be given so that more tumor cells are killed. Sometimes, after surgery, the tumor may not need more treatment until it progresses. In this case, observation may be sufficient. It is not yet known whether observation is more effective than combination chemotherapy, radiation therapy, and/or autologous stem cell transplant in treating neuroblastoma. PURPOSE: This randomized phase III and phase IV trial is studying observation, combination chemotherapy, radiation therapy, and/or autologous stem cell transplant to compare how well they work in treating young patients with neuroblastoma.

Conditions

  • Neuroblastoma

Interventions

  • filgrastimBiological

  • carboplatinDrug

  • cisplatinDrug

  • cyclophosphamideDrug

  • dacarbazineDrug

  • doxorubicin hydrochlorideDrug

  • etoposide phosphateDrug

  • ifosfamideDrug

  • isotretinoinDrug

  • melphalanDrug

  • topotecan hydrochlorideDrug

  • vincristine sulfateDrug

  • vindesineDrug

  • autologous hematopoietic stem cell transplantationProcedure

  • conventional surgeryProcedure

  • peripheral blood stem cell transplantationProcedure

  • iobenguane I 131Radiation

  • radiation therapyRadiation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Event-free survival (EFS)
  2. Locoregional EFS

Locations

80 sites in 2 countries. Site status is shown where the registry gives one.

  • Kinderklinik - Universitaetsklinikum Aachen

    Aachen, Germany · Recruiting

  • Klinikum Augsburg

    Augsburg, Germany · Recruiting

  • Klinikum am Bamberg

    Bamberg, Germany · Recruiting

  • Klinikum Bayreuth

    Bayreuth, Germany · Recruiting

  • Helios Klinikum Berlin

    Berlin, Germany · Recruiting

  • Charite University Hospital - Campus Virchow Klinikum

    Berlin, Germany · Recruiting

  • Evangelisches Krankenhauus Bielfeld

    Biefeld, Germany · Recruiting

  • Kinderklinik der Universitaet Bonn

    Bonn, Germany · Recruiting

  • Staedtisches Klinikum - Howedestrase

    Braunschweig, Germany · Recruiting

  • Klinikum Bremen-Mitte

    Bremen, Germany · Recruiting

  • Allgemeinen Krankenhaus Celle Kinderklinik

    Celle, Germany · Recruiting

  • Klinikum Chemnitz gGmbH

    Chemnitz, Germany · Recruiting

  • Klinikum Coburg

    Coburg, Germany · Recruiting

  • Kliniken der Stadt Koeln gGmbH - Kinderkrankenhaus Riehl

    Cologne, Germany · Recruiting

  • Children's Hospital

    Cologne, Germany · Recruiting

  • Carl - Thiem - Klinkum Cottbus

    Cottbus, Germany · Recruiting

  • Vestische Kinderklinik

    Datteln, Germany · Recruiting

  • Klinikum Lippe - Detmold

    Detmold, Germany · Recruiting

  • Klinikum Dortmund

    Dortmund, Germany · Recruiting

  • Universitatsklinikum Carl Gustav Carus

    Dresden, Germany · Recruiting

  • Klinikum Duisburg

    Duisburg, Germany · Recruiting

  • Universitaets - Frauenklinik, Duesseldorf

    Düsseldorf, Germany · Recruiting

  • Helios Klinikum Erfurt

    Erfurt, Germany · Recruiting

  • Universitaets - Kinderklinik

    Erlangen, Germany · Recruiting

  • Universitaetsklinikum Essen

    Essen, Germany · Recruiting

  • Klinikum der J.W. Goethe Universitaet

    Frankfurt, Germany · Recruiting

  • Universitaetskinderklinik - Universitaetsklinikum Freiburg

    Freiburg im Breisgau, Germany · Recruiting

  • Kinderklinik

    Giessen, Germany · Recruiting

  • Universitaetsklinikum Goettingen

    Göttingen, Germany · Recruiting

  • Universitats - Kinderklinik

    Greiswald, Germany · Recruiting

  • Universitaetsklinikum Halle

    Halle, Germany · Recruiting

  • Krankenhaus St. Elisabeth und St. Barbara

    Halle, Germany · Recruiting

  • University Medical Center Hamburg - Eppendorf

    Hamburg, Germany · Recruiting

  • Kinderkrankenhaus auf der Bult

    Hanover, Germany · Recruiting

  • Medizinische Hochschule Hannover

    Hanover, Germany · Recruiting

  • Universitaets-Kinderklinik Heidelberg

    Heidelberg, Germany · Recruiting

  • SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen

    Heilbronn, Germany · Recruiting

  • Gemeinschaftskrankenhaus

    Herdecke, Germany · Recruiting

  • Universitaetsklinikum des Saarlandes

    Homburg, Germany · Recruiting

  • Universitaets - Kinderklinik

    Jena, Germany · Recruiting

Showing 40 of 80 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.